Cell-cell communications create robust collective immunological responses
细胞间通讯产生强大的集体免疫反应
基本信息
- 批准号:9780029
- 负责人:
- 金额:$ 27.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AntigensAntitumor ResponseAutoantigensCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell CommunicationCell modelCellsCessation of lifeCuesFeedbackFrequenciesGoalsHeterogeneityImmune responseImmunityIndividualInterleukin-2LawsOutputPathway interactionsPopulationPredispositionProductionPropertyReactionSignal TransductionStimulusT cell responseT-Cell ActivationT-LymphocyteTimeTissuesTranslatingTumor AntigensWorkYanganaloganti-tumor immune responseantigen-specific T cellscytokineexhaustionparacrinequantumresponseself organizationtooltumor
项目摘要
We developed quantitative models of the cell-to-cell communications via cytokines amongst population of T lymphocytes. Our goal is to understand how T cells self-organize to decide their cell fate (e.g. between quiescence -tolerance- and death/proliferation -responses). At a fundamental level, we developed theoretical tools to analyze the heterogeneity and synchronicity of T cell responses in dense tissues. In the context of responses to tumor, we found that a critical mass of T cells existed to drive tumor rejection. Additional work is being carried out to dissect quantitatively how T cell decide collectively between tumor rejection and tumor tolerance.
我们通过细胞因子在T淋巴细胞群中建立了细胞间通讯的定量模型。我们的目标是了解T细胞如何自我组织来决定它们的细胞命运(例如,在沉默-耐受-和死亡/增殖-反应之间)。在基础水平上,我们开发了理论工具来分析致密组织中T细胞反应的异质性和同步性。在对肿瘤的反应中,我们发现存在临界质量的T细胞来驱动肿瘤排斥反应。更多的工作正在进行,以定量剖析T细胞如何在肿瘤排斥和肿瘤耐受之间共同决定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregoire Altan-Bonnet其他文献
Gregoire Altan-Bonnet的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregoire Altan-Bonnet', 18)}}的其他基金
Endogenous Heterogeneity of Signaling Pathways in Cancer
癌症信号通路的内源异质性
- 批准号:
8181559 - 财政年份:2010
- 资助金额:
$ 27.97万 - 项目类别:
Variability of Cellular Responses to Growth Factors and Drugs During Tumorgenesis
肿瘤发生过程中细胞对生长因子和药物反应的变异性
- 批准号:
8181539 - 财政年份:2010
- 资助金额:
$ 27.97万 - 项目类别:
Quantitative modeling of the phenotypic variability of individual T cells and the
个体 T 细胞表型变异的定量建模和
- 批准号:
8306678 - 财政年份:2009
- 资助金额:
$ 27.97万 - 项目类别:
Quantitative modeling of the phenotypic variability of individual T cells and the
个体 T 细胞表型变异的定量建模和
- 批准号:
7907546 - 财政年份:2009
- 资助金额:
$ 27.97万 - 项目类别:
Quantitative modeling of the phenotypic variability of individual T cells and the
个体 T 细胞表型变异的定量建模和
- 批准号:
7697433 - 财政年份:2009
- 资助金额:
$ 27.97万 - 项目类别:
Quantitative modeling of the phenotypic variability of individual T cells and the
个体 T 细胞表型变异的定量建模和
- 批准号:
8115954 - 财政年份:2009
- 资助金额:
$ 27.97万 - 项目类别:
Endogenous Heterogeneity of Signaling Pathways in Cancer
癌症信号通路的内源异质性
- 批准号:
8468148 - 财政年份:
- 资助金额:
$ 27.97万 - 项目类别:
Variability of Cellular Responses to Growth Factors and Drugs During Tumorgenesis
肿瘤发生过程中细胞对生长因子和药物反应的变异性
- 批准号:
8260217 - 财政年份:
- 资助金额:
$ 27.97万 - 项目类别:
Endogenous Heterogeneity of Signaling Pathways in Cancer
癌症信号通路的内源异质性
- 批准号:
8377739 - 财政年份:
- 资助金额:
$ 27.97万 - 项目类别:
相似海外基金
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
通过间质局部消融免疫疗法增强全身抗肿瘤反应,与转移性胰腺肿瘤的免疫检查点疗法协同作用
- 批准号:
10580071 - 财政年份:2022
- 资助金额:
$ 27.97万 - 项目类别:
Development of new cancer treatment utilizing the enhancement of antitumor response caused by allo reaction
利用同种异体反应增强抗肿瘤反应开发新的癌症治疗方法
- 批准号:
20K17649 - 财政年份:2020
- 资助金额:
$ 27.97万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of CD4 T cells and APCs in the induction and maintenance of an effective antitumor response
CD4 T 细胞和 APC 在诱导和维持有效抗肿瘤反应中的作用
- 批准号:
nhmrc : 143674 - 财政年份:2001
- 资助金额:
$ 27.97万 - 项目类别:
NHMRC Project Grants
ANTICD20 MEDIATED SIGNALING AND ANTITUMOR RESPONSE
ANTICD20 介导的信号传导和抗肿瘤反应
- 批准号:
2377164 - 财政年份:1997
- 资助金额:
$ 27.97万 - 项目类别:
ANTICD20 MEDIATED SIGNALING AND ANTITUMOR RESPONSE
ANTICD20 介导的信号传导和抗肿瘤反应
- 批准号:
2712876 - 财政年份:1997
- 资助金额:
$ 27.97万 - 项目类别: